Zeposia helps cognitive functionPublished: 09 August 2022 Zeposia (ozanimod) can help to stabilise or even improve cognition in people with multiple sclerosis (MS) according to a phase 3 clinical trial. Zeposia is taken orally and works by keeping immune cells within the lymph nodes, preventing them crossing into the brain and causing damage. The researchers said early, long-term treatment showed the best results as cognition was better preserved in people who had higher brain volume to begin with, before much damage had been done. Other Stories You May Be Interested In... News Oxygen depravation eases MS in study View article News UK MS diagnosis rate stays constant for 20 years with MS patients LESS likely to have other autoimmune conditions View article News Targeted nanocapsules offer hope for MS treatment in new study View article